Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
The Company has completed its admission to the Access segment of the AQSE Growth Market and trading will commence at 8:00 A.M. GM – Oct 10, 2023 – “MYIG”
VANCOUVER, British Columbia, Oct. 10, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group, Inc. (Mydecine or the Company) (CSE:MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE:0NFA), a biotechnology company engi…